NCT06287658 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Diener E, Wirtz D, Tov W, Kim-Prieto C, Choi D, Oishi S, Biswas-Diener R
New well-being measures: Short scales to assess flourishing and positive and negative feelings. Social Indicators Research, 2010; 97: 143-156.
Özerdogan N, Kizilkaya NB
Prevalence, risk factors, and impact on quality of life of urinary incontinence in women aged 20 and over in Eskisehir, Bilecik, Afyon, Kütahya provinces. Journal of Nursing 2003; 13:37-50.
Telef BB
Psychological Well-Being Scale (PIOO): Adaptation to Turkish, Validity and Reliability Study. Hacettepe Faculty of Education Journal, 2013; 28(3):374-384
Wagner TH, Patrick DL, Bavendam TG, Martin ML, Buesching DP
Quality of life of persons with urinary incontinence: development of a new measure. Urology. 1996 Jan;47(1):67-71; discussion 71-2. doi: 10.1016/s0090-4295(99)80384-7.

The Effect of Kegel Exercise and Ba Duan Jin Applications on Quality of Life and Psychological Well-Being Applied to Premenopausal Women With Urinary Incontinence

Details for clinical trial NCT06287658

Clinical trial NCT06287658 - References